Verena Labi
Has grant
Tenured / Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Verena Labi is a Tenured Associate Professor at the Medizinische Universität Innsbruck Biocenter, located in Austria. Her research areas include B cell development, tumorigenesis, neuroimmune responses, and T cell dynamics, as reflected in her recent publications. She contributes significantly to the understanding of cellular signaling pathways in the immune system and their implications in age-related conditions and infections.
Recent Grants
Grant: Close
BCL2 network adaptations in B cell transformation
Open Date: 2023-01-01
Close Date:
Grant: Close
Verena Labi
Open Date: 2020-01-01
Close Date:
Grant: Close
Verena Labi
Open Date: 2020-01-01
Close Date:
Grant: Close
Verena Labi
Open Date: 2016-01-01
Close Date: 2018-01-01
Grant: Close
Verena Labi
Open Date: 2016-01-01
Close Date: 2019-01-01
Articles (11)
Deregulated centrosome numbers are frequently found in human cancer and can promote malignancies in model organisms. Current research aims to clarify if extra centrosomes are cause or consequence of malignant transformation, and if their biogenesis can be targeted for therapy. Here, we show that oncogene-driven blood cancer is inert to genetic manipulation of centrosome numbers, whereas the formation of DNA damage–induced malignancies is delayed. We provide first evidence that this unexpected phenomenon is connected to extra centrosomes eliciting a pro-death signal engaging the apoptotic machinery. Apoptosis induction requires the PIDDosome multi-protein complex, as it can be abrogated by loss of any of its three components, Caspase-2 , Raidd/Cradd , or Pidd1 . BCL2 overexpression equally blocks cell death, documenting for the first time induction of mitochondrial apoptosis downstream of extra centrosomes. Our findings demonstrate context-dependent effects of centrosome amplification during transformation and ask to adjust current belief that extra centrosomes are intrinsically pro-tumorigenic.
Year:
2024
Year:
2024
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (5)
Gottfried Baier
Medical University of Innsbruck
Andreas Villunger
Medical University of Innsbruck
Thomas Gruber
Assoz.-Prof. Dr.
Medical University of Innsbruck
Eva Kiermaier
Professor
-
Sebastian Herzog
Medical University of Innsbruck
Make your next move.
Prepare your application
Review drafts before you send them.